The shares of Pfizer Inc. have increased by more than 0.44% this year alone. The shares recently went down by -0.16% or -$0.06 and now trades at $36.38. The shares of Raytheon Company (NYSE:RTN), has jumped by 13.35% year to date as of 06/06/2018. The shares currently trade at $212.92 and have been able to report a change of 0.28% over the past one week.

The stock of Pfizer Inc. and Raytheon Company were two of the most active stocks on Wednesday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

**Next 5Y EPS Growth: 6.88% versus 24.90%**

When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that PFE will grow it’s earning at a 6.88% annual rate in the next 5 years. This is in contrast to RTN which will have a positive growth at a 24.90% annual rate. This means that the higher growth rate of RTN implies a greater potential for capital appreciation over the years.

**Profitability and Returns**

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. PFE has an EBITDA margin of 30.72%, this implies that the underlying business of PFE is more profitable. The ROI of PFE is 9.90% while that of RTN is 15.80%. These figures suggest that RTN ventures generate a higher ROI than that of PFE.

**Cash Flow**

The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, PFE’s free cash flow per share is a negative -0.79, while that of RTN is also a negative -0.65.

**Liquidity and Financial Risk**

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for PFE is 1.30 and that of RTN is 1.60. This implies that it is easier for PFE to cover its immediate obligations over the next 12 months than RTN. The debt ratio of PFE is 0.58 compared to 0.49 for RTN. PFE can be able to settle its long-term debts and thus is a lower financial risk than RTN.

**Valuation**

PFE currently trades at a forward P/E of 11.86, a P/B of 3.09, and a P/S of 4.11 while RTN trades at a forward P/E of 18.68, a P/B of 6.00, and a P/S of 2.40. This means that looking at the earnings, book values and sales basis, PFE is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

**Analyst Price Targets and Opinions**

The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of PFE is currently at a -8.13% to its one-year price target of 39.60. Looking at its rival pricing, RTN is at a -11.24% relative to its price target of 239.89.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), PFE is given a 2.60 while 1.80 placed for RTN. This means that analysts are more bullish on the outlook for PFE stocks.

**Insider Activity and Investor Sentiment**

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for PFE is 2.95 while that of RTN is just 2.66. This means that analysts are more bullish on the forecast for RTN stock.

Conclusion

The stock of Pfizer Inc. defeats that of Raytheon Company when the two are compared, with PFE taking 4 out of the total factors that were been considered. PFE happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, PFE is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for PFE is better on when it is viewed on short interest.